• 1
    Zhang WJ, Hufnagl P, Binder BR, Wojta J. Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-kappaB activation and adhesion molecule expression. Thromb Haemost 2003; 90: 90414.
  • 2
    Ma Z, Yang Z. Scavenging effects of Astragalus and Gynostemma pentaphyllum with its product on O2- and OH. Zhong Yao Cai 1999; 22: 3036. Chinese.
  • 3
    Zhang Y, Zhu H, Huang C, Cui X, Gao Y, Huang Y, et al. Astragalo-side IV exerts antiviral effects against coxsackievirus B3 by upregulating interferon-gamma. J Cardiovasc Pharmacol 2006; 47: 1905.
  • 4
    Xu ME, Xiao SZ, Sun YH, Ou-Yang Y, Zheng XX. Effects of astragaloside IV on pathogenesis of metabolic syndrome in vitro. Acta Pharmacol Sin 2006; 27: 22936.
  • 5
    Wang YP, Li XY, Song CQ, Hu ZB. Effect of astragaloside IV on T, B lymphocyte proliferation and peritoneal macrophage function in mice. Acta Pharmacol Sin 2002; 23: 2636.
  • 6
    Zhang WD, Chen H, Zhang C, Liu RH, Li HL, Chen HZ. Astragaloside IV from Astragalus membranaceus shows cardioprotection during myocardial ischemia in vivo and in vitro. Planta Med 2006; 72: 48.
  • 7
    Luo Y, Qin Z, Hong Z, Zhang X, Ding D, Fu JH, et al. Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia. Neurosci Lett 2004; 363: 21823.
  • 8
    Li ZP, Cao Q. Effects of astragaloside IV on myocardial calcium transport and cardiac function in ischemic rats. Acta Pharmacol Sin 2002; 23: 898904. Chinese.
  • 9
    Luo HM, Dai RH, Li Y. Nuclear cardiology study on effective ingredients of Astragalus membranaceus in treating heart failure. Zhongguo Zhong Xi Yi Jie He Za Zhi 1995; 15: 7079. Chinese.
  • 10
    Navarrete A, Arrieta J, Terrones L, Abou-Gazar H, Calis I. Gastro-protective effect of Astragaloside IV: role of prostaglandins, sulfhydryls and nitric oxide. J Pharm Pharmacol 2005; 57: 105964.
  • 11
    Muller TH, Swandulla D, Zeilhofer HU. Synaptic connectivity in cultured hypothalamic neuronal networks. J Neurophysiol 1997; 77: 321825.
  • 12
    Leinekugel X, Medina I, Khalilov I, Ben-Ari Y, Khazipov R. Ca2+ oscillations mediated by the synergistic excitatory actions of GABA(A) and NMDA receptors in the neonatal hippocampus. Neuron 1997; 18: 24355.
  • 13
    Liu Z, Geng L, Li R, He X, Zheng JQ, Xie Z. Frequency modulation of synchronized Ca2+ spikes in cultured hippocampal networks through G-protein-coupled receptors. J Neurosci 2003; 23: 415663.
  • 14
    Bacci A, Verderio C, Pravettoni E, Matteoli M. Synaptic and intrinsic mechanisms shape synchronous oscillations in hippocampal neurons in culture. Eur J Neurosci 1999; 11: 38997.
  • 15
    Tanaka T, Saito H, Matsuki N. Intracellular calcium oscillation in cultured rat hippocampal neurons: a model for glutamatergic neurotransmission. Jpn J Pharmacol 1996; 70: 8993.
  • 16
    Dravid SM, Murray TF. Spontaneous synchronized calcium oscillations in neocortical neurons in the presence of physiological (Mg[2+]): involvement of AMPA/kainate and metabotropic glutamate receptors. Brain Res 2004; 1006: 817.
  • 17
    Koller H, Siebler M, Schmalenbach C, Muller HW. GABA and glutamate receptor development of cultured neurons from rat hippocampus, septal region, and neocortex. Synapse 1990; 5: 5964.
  • 18
    Moody WJ. Control of spontaneous activity during development. J Neurobiol 1998; 37: 97109.
  • 19
    Hodgkin AL, Huxley AF, Katz B. Measurement of current-voltage relations in the membrane of the giant axon of Loligo. J Physiol 1952; 116: 42448.
  • 20
    Engel D, Jonas P. Presynaptic action potential amplification by voltage-gated Na+ channels in hippocampal mossy fiber boutons. Neuron 2005; 45: 40517.
  • 21
    Yost CS. Potassium channels: basic aspects, functional roles, and medical significance. Anesthesiology 1999; 90: 1186203.
  • 22
    Banker GA, Cowan WM. Rat hippocampal neurons in dispersed cell culture. Brain Res 1977; 126: 39742.
  • 23
    Bartlett WP, Banker GA. An electron microscopic study of the development of axons and dendrites by hippocampal neurons in culture. II. Synaptic relationships. J Neurosci 1984; 4: 195465.
  • 24
    Benson DL, Watkins FH, Steward O, Banker G. Characterization of GABAergic neurons in hippocampal cell cultures. J Neurocytol 1994; 23: 27995.
  • 25
    Li L, Tao HY, Chen JB. Anti-apoptosis effect of astragaloside on adriamycin induced rat's cardiotoxicity. Zhongguo Zhong Xi Yi Jie He Za Zhi 2006; 26: 10114. Chinese.
  • 26
    Marszalec W, Song JH and Narahashi T. The effects of the muscle relaxant, CS-722, on synaptic activity of cultured neurons. Br J Pharmacol 1996; 119: 12632.
  • 27
    Gu Y, Wang G, Pan G, Fawcett JP, Fawcett AJ, Sun J. Transport and bioavailability studies of astragaloside IV, an active ingredient in Radix Astragali. Basic Clin Pharmacol Toxicol 2004; 95: 2958.
  • 28
    Huang CR, Wang GJ, Wu XL, Li H, Xie HT, Lv H, et al. Absorption enhancement study of astragaloside IV based on its transport mechanism in caco-2 cells. Eur J Drug Metab Pharmacokinet 2006; 31: 510.
  • 29
    Choi DW. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci 1988; 11: 4659.
  • 30
    Rothman SM, Olney JW. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 1986; 19: 10511.
  • 31
    Goldin SM, Subbarao K, Sharma R, Knapp AG, Fischer JB, Daly D, et al. Neuroprotective use-dependent blockers of Na+ and Ca2+ channels controlling presynaptic release of glutamate. Ann N Y Acad Sci 1995; 765: 21029.
  • 32
    Taylor CP, Meldrum BS. Na+ channels as targets for neuroprotective drugs. Trends Pharmacol Sci 1995; 16: 30916.
  • 33
    Lee JM, Zipfel GJ, Choi DW. The changing landscape of ischaemic brain injury mechanisms. Nature 1999; 399: A714.